ICJIM
Intercontinental Journal of Internal Medicine

The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics.

eISSN: 2980-0846
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Staphylococcus aureus nasal carriage rates, and risk factors in hemodialysis patients
Abstract
Aims: The aim of this study is to determine the rates of Staphylococcus aureus (S. aureus) nasal carriage, considered one of the most important sources of infection in patients undergoing haemodialysis treatment due to chronic kidney disease, and the susceptibility of S. aureus to mupirocin and fusidic acid.
Methods: The study included a total of 165 patients, comprising 55 women (33.3%) and 109 men (66.03%), who had been receiving treatment at the same dialysis centre for at least one year and underwent haemodialysis three times a week. Nasal swab samples were inoculated onto mannitol-salt agar (Beslab, Turkey). The media were incubated at 37 °C for 72 hours. Methicillin resistance was determined on Mueller-Hinton agar medium using cefoxitin discs (Bioanalyse, Turkey), and mupirocin and fusidic acid sensitivities were determined using the disc diffusion method with discs of these antibiotics (Bioanalyse, Turkey).
Results: A total of 165 patients were tested, and S. aureus was detected in 14 (8.48%); 9 (5.45%) were meticillin-sensitive; of the sensitive strains, 2 were resistant to mupirocin and 2 were resistant to fusidic acid. In 5 (3.03%) of the 165 patients, methicillin-resistant S. aureus was detected; 1 was resistant to mupirocin and 1 was resistant to fusidic acid.
Conclusion: It has been found that the rate of S. aureus nasal carriage is low in haemodialysis patients. The resistance rates of methicillin-sensitive strains to mupirocin and fusidic acid were higher than the resistance rates of susceptible strains. Eliminating nasal carriage is an important approach to protecting dialysis patients from infection.

Keywords : Hemodialysis patients, nasal carriage, Staphylococcus aureus, mupirocin, fusidic acid

Download Article


1. Wong YT, Yeung CS, Chak WL, Cheung CY. Methicillin-resistant Staphylococcus aureus nasal carriage among patients on haemodialysis with newly inserted central venous catheters. Int Urol Nephrol. 2023; 55(8):2059-2066. doi:10.1007/s11255-023-03521-4
2. Bokhari SFH, Iqbal A, Usman S, et al.A comprehensive review of infection risks and management in hemodialysis access sites. Clin Exp Nephrol. 2025. doi:10.1007/s10157-025-02790-w
3. Alves MA. Staphylococcal infections and kidney disease. In: Bezerra da Silva Junior G, De Francesco Daher E, Barros E. (eds). Tropical Nephrology. Sustainable Development Goals Series. Springer, Cham. 2025;301-306. doi:10.1007/978-3-031-94777-3_27
4. Çifci A, Erol ÖÖ, Kaya Ç, Ergen E, Cesur S. Hemodiyaliz hastalarında MRSA burun taşıyıcılığı ve VRE rektal taşıyıcılığı oranlarının belirlenmesi. Ortadoğu Tıp Derg. 2013;5(4):214-218.
5. Bezerra DT, Mesquita-Ferrari RA, Fernandes KPS, et al. Prevalence of nasalStaphylococcus aureus carriage in patients undergoing hemodialysis and assessment of risk factors: a cross-sectional study of outpatients at a university hospital. Healthcare. 2025; 13(3):245. doi.10. 3390/healthcare13030245
6. Swetha PS, Gupta K, Saha S, Panda SK, Behera B. Predictors for multidrug-resistant organisms (MDROs) carriage in haemodialysis patients. J Fam Med Prim Care. 2024;13(2):486-491. doi:10.4103/jfmpc.jfmpc_708_23
7. Aljehani RW. Catheter-related infection in hemodialysis patients atKing Faisal Specialist Hospital-a retrospective study (Master's thesis, Alfaisal University (Saudi Arabia)). ProQuest Dissertations & Theses, 2025:31770432.
8. Cesur S, Kurşun Ö, Aylı D, et al. Ayaktan takip edilen hemodiyaliz hastalarında Staphylococcus aureus nazal taşıyıcılığı oranları ve izole edilen suşların mupirosin, fusidik asit, trimetoprim-sulfametoksazol duyarlılıkları. Ortadoğu Tıp Derg. 2016;8(4):177-181. doi:10.21601/ortadogutipdergisi.271051
9. Scheuch M, Freiin von Rheinbaben S, Kabisch A, et al. Staphylococcus aureus colonization in hemodialysis patients: a prospective 25 months observational study. BMC Nephrol. 2019;20(1):153. doi:10.1186/s12882-019-1332-z
10. Kurutepe S, Gaz H, Sürücüoğlu S, Aktaş E, Özbakkaloğlu B. Klinik ve pre-klinik hastane personelinde metisiline direncli Staphylococcus aureus burun taşıyıcılık oranları. Türk Mikrobiyol Cem Derg. 2005; 35:178-182.
11. Mutlu B, Gündeş S, Kolaylı F, et al. Hastane personelinin burun kültürlerinden izole edilen stafilokok türlerinin metisilin duyarlılığı. Klimik Derg. 2001;14(3):159-160.
12. Ferreira MAM, Pires PPA, Dos Santos KV. Staphylococcus aureus nasal colonization and susceptibility profile to antimicrobials in hemodialysis patients using a protocol of seven collections. Diagnostic Microbiol Infec Dis. 2023;109(2):116295. doi:10.1016/j. diagmicrobio.2024.116295
13. Çelik G, Gülcan A. Hemodiyaliz tedavisi alan hastalarda nazal Staphylococcus aureus taşıyıcılığı ve risk faktörlerinin belirlenmesi. Türk Mikrobiyol Cem Derg. 2010;40(2):79-86.
14. Lu PL, Tsai JC, Chiu YW, et al. Methicillin resistant Staphylococcus aureus carriage, infection andtransmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant. 2008;23:1659-1665. doi:10.1093/ndt/gfm806
15. Lederer SR, Riedelsdorf G, Schiffl H. Nasal carriage of Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res. 2007; 12:284-288
Article available in :
Volume 4, Issue 1, 2026
Page : 9-12
https://doi.org/10.51271/ICJIM-0068
Article Information
Received : 30 Oca 2026
Accepted : 24 Şub 2026
Published : 28 Şub 2026
Corresponding Author :

Hakkı Öztürk: Infectious Diseases Epidemiologist, Private Ankara Dialysis Center, Ankara, Turkiye

[email protected]
Citation : Öztürk H, Özsoy M. Staphylococcus aureus nasal carriage rates, and risk factors in hemodialysis patients. Intercont J Int Med. 2026;4(1):9-12.

Read: 21
Download : 47
Cited: 0
_Footer